Good levels to buy TRVN

١٧ نوفمبر ٢٠٢٠

Very bullish for NASDAQ:TRVN in the long term.
- High demand product with blockbuster drug good for opiod crisis.
- Potential replacement for morphine, no real competitor
- Partnership with Syneos for sales
- Potential buyout

Good levels to buy at 2.50 and 2.33

Should see rise towards next quarter earnings.

Long term PTs
TP1 - $5
TP2 - $15
TP3 - $30

٨ ديسمبر ٢٠٢٠

ملاحظة

hold

٢٧ ديسمبر ٢٠٢٠

ملاحظة

Falling wedge pattern in the short term and an ascending triangle on the mid term.

Continue hold towards next quarter earnings in March

٦ يناير ٢٠٢١

تم فتح الصفقة

finance.yahoo.com/news/trevena-inc-provides-commercial-launch-120000483.html

٧ يناير ٢٠٢١

ملاحظة

Seems to breaking out of the falling wedge